Evidence map›Paper›PMID 35781146›Full record

ReviewGaceta sanitaria2022

[What have we missed because of COVID-19? Missed diagnoses and delayed follow-ups. SESPAS Report 2022].

Isabel Del Cura-González, Elena Polentinos-Castro, Mario Fontán-Vela, Juan A López-Rodríguez, Jesús Martín-Fernández

Open access · goldAbstract readReview
In one paragraph

Review in Gaceta sanitaria, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Article
  14. Observational
  15. Observational
  16. Article
  17. [Open data for monitoring COVID-19 in Spain: descriptive study].Enfermedades infecciosas y microbiologia clinica · 2022
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Isabel Del Cura-GonzálezUnidad de Investigación, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, España; Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, España; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) - Instituto de Salud Carlos III, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España. Electronic address: Isabel.cura@salud.madrid.org.
Elena Polentinos-CastroUnidad de Investigación, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, España; Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, España; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) - Instituto de Salud Carlos III, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España.
Mario Fontán-VelaServicio de Medicina Preventiva, Hospital Infanta Leonor, Madrid, España; Grupo de Investigación en Salud Pública y Epidemiología, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España.
Juan A López-RodríguezUnidad de Investigación, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, España; Departamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, España; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) - Instituto de Salud Carlos III, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España; Centro de Salud General Ricardos, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, España.
Jesús Martín-FernándezDepartamento de Especialidades Médicas y Salud Pública, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Madrid, España; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC) - Instituto de Salud Carlos III, Madrid, España; Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, España; Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Oeste, Gerencia Asistencial Atención Primaria, Servicio Madrileño de Salud, Madrid, España.
Hospital General Universitario Gregorio Marañón · ESUniversidad Rey Juan Carlos · ESUniversidad de Alcalá · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic and the associated public health emergency have affected patients and health services in non-COVID-19 pathologies. Several studies have shown its dissociation from health services, with a decrease in emergency department visits, in hospital admissions for non-COVID-19 pathologies, as well as in the reported weekly incidence of acute illnesses and new diagnoses in primary care. In parallel, the pandemic has had direct and indirect effects on people with chronic diseases; the difficulties in accessing health services, the interruption of care, the saturation of the system itself and its reorientation towards non-face-to-face formats has reduced the capacity to prevent or control chronic diseases. All this has also had an impact on the different areas of people's lives, creating new social and economic difficulties, or aggravating those that existed before the pandemic. All these circumstances have changed with each epidemic wave. We present a review of the most relevant studies that have been analyzing this problem and incorporate as a case study the results of a retrospective observational study carried out in Primary Care in the Madrid Health Service, which provides health coverage to a population of more than 6 million people, and whose objective was to analyze the loss of new diagnoses in the most prevalent pathologies such as common mental health problems, cardiovascular and cerebrovascular diseases, type 2 diabetes, chronic obstructive pulmonary disease, and breast and colon tumors, in the first and second waves. Annual incidence rates with their confidence interval were calculated for each pathology and the monthly frequency of new codes recorded between 1/01/2020 and 12/31/2020 was compared with the monthly mean of observed counts for the same months between 2016 and 2019. The annual incidence rate for all processes studied decreased in 2020 except for anxiety disorders. Regarding the recovery of lost diagnoses, heart failure is the only diagnosis showing an above-average recovery after the first wave. To return to pre-pandemic levels of diagnosis and follow-up of non-COVID-19 pathology, the healthcare system must reorganize and contemplate specific actions for the groups at highest risk.

Indexed as

COVID-19Diabetes Mellitus, Type 2Follow-Up StudiesHumansMissed DiagnosisObservational Studies as TopicPandemicsAtención primariaChronic diseasesCOVID-19Diagnósticos perdidosEnfermedades crónicasFollow-upHealth servicesMissed diagnosesPrimary health careSARS-CoV-2SeguimientosServicios de salud

Identifiers

PMID35781146
PMCPMC9244613
OpenAlexW4285131534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.